Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxaluria, Primary | 3 | 2024 | 24 | 1.950 |
Why?
|
| Cystinuria | 3 | 2020 | 19 | 1.030 |
Why?
|
| Hyperoxaluria | 2 | 2022 | 32 | 1.010 |
Why?
|
| Spinal Dysraphism | 7 | 2022 | 174 | 0.910 |
Why?
|
| Nephrolithiasis | 6 | 2024 | 114 | 0.870 |
Why?
|
| Urinary Tract | 4 | 2021 | 309 | 0.840 |
Why?
|
| Kidney Tubules, Collecting | 5 | 2017 | 163 | 0.620 |
Why?
|
| Urologic Diseases | 1 | 2019 | 248 | 0.550 |
Why?
|
| Renal Replacement Therapy | 8 | 2012 | 281 | 0.540 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2004 | 325 | 0.500 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2021 | 174 | 0.440 |
Why?
|
| Urogenital Abnormalities | 3 | 2021 | 256 | 0.430 |
Why?
|
| Kidney Cortex | 1 | 2011 | 169 | 0.390 |
Why?
|
| Nephrocalcinosis | 3 | 2017 | 52 | 0.390 |
Why?
|
| Kidney Transplantation | 7 | 2024 | 4215 | 0.390 |
Why?
|
| Meningomyelocele | 2 | 2021 | 170 | 0.330 |
Why?
|
| Urolithiasis | 2 | 2022 | 132 | 0.300 |
Why?
|
| Oxalates | 3 | 2022 | 98 | 0.300 |
Why?
|
| Kidney Calculi | 2 | 2022 | 468 | 0.270 |
Why?
|
| Sodium | 1 | 2011 | 1594 | 0.270 |
Why?
|
| Denys-Drash Syndrome | 1 | 2005 | 7 | 0.260 |
Why?
|
| Aquaporins | 3 | 2003 | 174 | 0.240 |
Why?
|
| Wilms Tumor | 1 | 2005 | 375 | 0.200 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2022 | 151 | 0.190 |
Why?
|
| Graft Survival | 5 | 2019 | 3794 | 0.190 |
Why?
|
| Renal Dialysis | 4 | 2024 | 1801 | 0.180 |
Why?
|
| Infant | 20 | 2021 | 36060 | 0.170 |
Why?
|
| Living Donors | 2 | 2002 | 636 | 0.170 |
Why?
|
| Kidney Function Tests | 2 | 2020 | 681 | 0.170 |
Why?
|
| Acidosis, Renal Tubular | 1 | 2019 | 50 | 0.170 |
Why?
|
| Kidney | 6 | 2021 | 7064 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2024 | 1180 | 0.160 |
Why?
|
| Pedigree | 4 | 2020 | 4578 | 0.160 |
Why?
|
| Cations, Divalent | 1 | 1998 | 168 | 0.160 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2021 | 438 | 0.150 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2019 | 196 | 0.150 |
Why?
|
| Child | 26 | 2022 | 79806 | 0.150 |
Why?
|
| Body Water | 1 | 1998 | 341 | 0.140 |
Why?
|
| Minerals | 1 | 1998 | 283 | 0.140 |
Why?
|
| Hypertension, Renovascular | 1 | 1997 | 117 | 0.140 |
Why?
|
| RNA Interference | 2 | 2022 | 2846 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 190 | 0.140 |
Why?
|
| Child, Preschool | 20 | 2022 | 42063 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1612 | 0.130 |
Why?
|
| Infant, Newborn | 13 | 2021 | 26181 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2021 | 643 | 0.130 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
| Marfan Syndrome | 1 | 1997 | 236 | 0.120 |
Why?
|
| Dietary Proteins | 2 | 2011 | 949 | 0.120 |
Why?
|
| Mutation | 6 | 2020 | 29932 | 0.120 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 814 | 0.120 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 299 | 0.110 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 391 | 0.110 |
Why?
|
| Ion Channels | 1 | 1998 | 1043 | 0.110 |
Why?
|
| Adolescent | 19 | 2020 | 87810 | 0.110 |
Why?
|
| Epithelium | 1 | 2017 | 1605 | 0.110 |
Why?
|
| Humans | 45 | 2024 | 760621 | 0.100 |
Why?
|
| Urologic Surgical Procedures | 1 | 2015 | 309 | 0.100 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2012 | 38 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2024 | 2325 | 0.100 |
Why?
|
| Amiloride | 1 | 2011 | 116 | 0.100 |
Why?
|
| Diet, Protein-Restricted | 1 | 2011 | 73 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1440 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 285 | 0.090 |
Why?
|
| Male | 29 | 2022 | 359744 | 0.090 |
Why?
|
| Kidney Medulla | 2 | 2001 | 169 | 0.080 |
Why?
|
| Female | 26 | 2022 | 391270 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2981 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 17790 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2020 | 2608 | 0.080 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2009 | 109 | 0.080 |
Why?
|
| Urodynamics | 2 | 2021 | 346 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2011 | 8158 | 0.080 |
Why?
|
| Diuretics | 1 | 2011 | 613 | 0.080 |
Why?
|
| Kidney Diseases | 2 | 2012 | 2093 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 4312 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 389 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12427 | 0.080 |
Why?
|
| Graft Rejection | 4 | 2019 | 4426 | 0.070 |
Why?
|
| Biological Transport | 1 | 2011 | 2086 | 0.070 |
Why?
|
| Nutritional Support | 1 | 2008 | 172 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3758 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2020 | 8555 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1998 | 3604 | 0.070 |
Why?
|
| Aldosterone | 1 | 2011 | 868 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2019 | 65017 | 0.070 |
Why?
|
| Registries | 6 | 2020 | 8469 | 0.070 |
Why?
|
| Fetal Development | 1 | 2011 | 766 | 0.070 |
Why?
|
| Aquaporin 6 | 3 | 2003 | 44 | 0.070 |
Why?
|
| Recurrence | 3 | 2004 | 8482 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2065 | 0.060 |
Why?
|
| Citric Acid | 1 | 2005 | 123 | 0.060 |
Why?
|
| Aquaporin 2 | 3 | 2003 | 126 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2019 | 4107 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2290 | 0.060 |
Why?
|
| Dogfish | 1 | 2003 | 11 | 0.060 |
Why?
|
| Prospective Studies | 7 | 2021 | 54303 | 0.060 |
Why?
|
| Dihydrotachysterol | 1 | 2003 | 4 | 0.060 |
Why?
|
| Algorithms | 1 | 2024 | 13981 | 0.060 |
Why?
|
| Rats | 5 | 2011 | 23711 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2005 | 367 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9585 | 0.050 |
Why?
|
| Calpain | 1 | 2003 | 145 | 0.050 |
Why?
|
| Calcium Oxalate | 1 | 2022 | 75 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2005 | 386 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2471 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2003 | 1067 | 0.050 |
Why?
|
| Young Adult | 5 | 2020 | 58741 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3790 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
| Energy Intake | 1 | 2008 | 2129 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Calcineurin | 1 | 2001 | 229 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12103 | 0.050 |
Why?
|
| beta Carotene | 1 | 2022 | 524 | 0.040 |
Why?
|
| Hostility | 1 | 2021 | 183 | 0.040 |
Why?
|
| Cystine | 1 | 2020 | 94 | 0.040 |
Why?
|
| Mutation, Missense | 2 | 2022 | 2566 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2019 | 103 | 0.040 |
Why?
|
| Animals | 11 | 2022 | 167963 | 0.040 |
Why?
|
| Magnesium | 1 | 2003 | 810 | 0.040 |
Why?
|
| Adult | 11 | 2021 | 219994 | 0.040 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 1 | 2019 | 150 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 483 | 0.040 |
Why?
|
| Prognosis | 4 | 2019 | 29658 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 1599 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2011 | 2496 | 0.040 |
Why?
|
| Calcium, Dietary | 1 | 2022 | 531 | 0.040 |
Why?
|
| Calcium | 3 | 2022 | 5725 | 0.040 |
Why?
|
| Aquaporin 3 | 1 | 1998 | 14 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 509 | 0.040 |
Why?
|
| Arginine Vasopressin | 1 | 1998 | 125 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 717 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2717 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 691 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 1998 | 106 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 1313 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2016 | 1649 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8594 | 0.040 |
Why?
|
| Heparin | 1 | 2005 | 1652 | 0.040 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2017 | 86 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 420 | 0.040 |
Why?
|
| Heredity | 1 | 2017 | 148 | 0.040 |
Why?
|
| Homeostasis | 2 | 2017 | 3306 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 575 | 0.030 |
Why?
|
| Vasopressins | 1 | 1998 | 355 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 1941 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2019 | 41335 | 0.030 |
Why?
|
| Urea | 1 | 1998 | 446 | 0.030 |
Why?
|
| Phenotype | 3 | 2018 | 16546 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2017 | 279 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2017 | 382 | 0.030 |
Why?
|
| Ureter | 1 | 1998 | 375 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 13451 | 0.030 |
Why?
|
| Hypercalcemia | 1 | 1998 | 421 | 0.030 |
Why?
|
| Bicarbonates | 1 | 2016 | 292 | 0.030 |
Why?
|
| Sulfates | 1 | 2016 | 379 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2018 | 625 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2017 | 2913 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2017 | 383 | 0.030 |
Why?
|
| Urography | 1 | 2015 | 312 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 3616 | 0.030 |
Why?
|
| Ureteroscopy | 1 | 2015 | 148 | 0.030 |
Why?
|
| Endosomes | 3 | 2003 | 519 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2017 | 5961 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2008 | 15697 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14372 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 2798 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2020 | 1166 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2022 | 22053 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2295 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2019 | 10182 | 0.030 |
Why?
|
| Hemodialysis Solutions | 1 | 2012 | 7 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 1096 | 0.030 |
Why?
|
| Risk Factors | 4 | 2022 | 74359 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 1998 | 2672 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 730 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 81208 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 867 | 0.030 |
Why?
|
| Protein Binding | 2 | 2020 | 9335 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1190 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 2753 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 2471 | 0.020 |
Why?
|
| Water | 1 | 1998 | 1407 | 0.020 |
Why?
|
| Epitopes | 1 | 1998 | 2503 | 0.020 |
Why?
|
| Syndrome | 1 | 2018 | 3280 | 0.020 |
Why?
|
| Incidence | 2 | 2021 | 21392 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2608 | 0.020 |
Why?
|
| Survival Rate | 3 | 2014 | 12808 | 0.020 |
Why?
|
| United States | 5 | 2020 | 72461 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12965 | 0.020 |
Why?
|
| Age of Onset | 1 | 2017 | 3301 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6898 | 0.020 |
Why?
|
| Fibrosis | 1 | 2017 | 2042 | 0.020 |
Why?
|
| Protein Transport | 1 | 2016 | 1964 | 0.020 |
Why?
|
| Retrospective Studies | 5 | 2020 | 80372 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3113 | 0.020 |
Why?
|
| Antibodies | 1 | 1998 | 2421 | 0.020 |
Why?
|
| Pregnancy | 1 | 2011 | 29749 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 4166 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1854 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3189 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2005 | 4897 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 2825 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1894 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 4433 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4938 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3969 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1636 | 0.020 |
Why?
|
| Hemofiltration | 1 | 2008 | 59 | 0.020 |
Why?
|
| Age Factors | 1 | 2004 | 18416 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 24123 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
| Critical Illness | 2 | 2009 | 2709 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9280 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3531 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 17624 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 7588 | 0.010 |
Why?
|
| Diet | 1 | 2022 | 8010 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20509 | 0.010 |
Why?
|
| Cell Line | 1 | 2017 | 15620 | 0.010 |
Why?
|
| Leupeptins | 1 | 2003 | 113 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14660 | 0.010 |
Why?
|
| Immune Sera | 1 | 2003 | 613 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12960 | 0.010 |
Why?
|
| Caseins | 1 | 2003 | 103 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 189 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 18137 | 0.010 |
Why?
|
| Trypsin | 1 | 2003 | 496 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2001 | 10 | 0.010 |
Why?
|
| Demography | 1 | 2007 | 1650 | 0.010 |
Why?
|
| Nephrons | 1 | 2003 | 168 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2001 | 176 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2003 | 5870 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2008 | 1014 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2005 | 560 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15289 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2003 | 1060 | 0.010 |
Why?
|
| Dextrans | 1 | 2003 | 574 | 0.010 |
Why?
|
| Autoradiography | 1 | 2001 | 730 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15840 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13502 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 9716 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6238 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39261 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2003 | 11071 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1744 | 0.010 |
Why?
|
| Aging | 1 | 1998 | 8651 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8035 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 15687 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5877 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 23376 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1792 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20080 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2001 | 1199 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12159 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 3600 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 4810 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10827 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2001 | 8313 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1998 | 2180 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 9287 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 220352 | 0.000 |
Why?
|
Concepts
(264)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_